Financials data is unavailable for this security.
View more
Year on year Krebs Biochemicals and Industries Ltd had revenues fall -3.29% from 521.34m to 504.22m, though the company grew net income from a loss of 246.92m to a smaller loss of 197.28m.
Gross margin | 85.82% |
---|---|
Net profit margin | -37.11% |
Operating margin | -28.64% |
Return on assets | -- |
---|---|
Return on equity | -- |
Return on investment | -- |
More ▼
Cash flow in INRView more
In 2024, Krebs Biochemicals and Industries Ltd increased its cash reserves by 60.14%, or 516.00k. Cash Flow from Financing totalled 55.64m or 11.04% of revenues. In addition the company generated 23.04m in cash from operations while cash used for investing totalled 78.17m.
Cash flow per share | -5.92 |
---|---|
Price/Cash flow per share | -- |
Book value per share | -- |
---|---|
Tangible book value per share | -- |
More ▼
Balance sheet in INRView more
Current ratio | -- |
---|---|
Quick ratio | -- |
Total debt/total equity | -- |
---|---|
Total debt/total capital | -- |
More ▼